TrialEye (London, England)2017

Appropriateness of quality standards for meaningful intercentre comparisons of aflibercept service provision for neovascular age-related macular degeneration.

J S Talks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.